Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | KU-60019 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | ETP-46464 | CTRPv2 | pan-cancer | AAC | 0.0021 | 1 |
mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.0017 | 1 |
mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |
mRNA | BRD-K61166597 | CTRPv2 | pan-cancer | AAC | -0.0013 | 1 |
mRNA | BRD-K41597374 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
mRNA | SR-II-138A | CTRPv2 | pan-cancer | AAC | -0.001 | 1 |
mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0016 | 1 |